DCB Funding Opportunities
Notices of Funding Opportunities (NOFOs)
| Title | Announcement Number | Opening Date | Expiration Date | Activity Code |
|---|---|---|---|---|
| Mechanistic links between diet, lipid metabolism, and tumor growth and progression (U01 Clinical Trial Not Allowed) | PAR-25-119 | 01/14/2025 | 10/24/2025 | U01 |
| Mechanistic links between diet, lipid metabolism, and tumor growth and progression (UH2 Clinical Trial Not Allowed) | PAR-25-118 | 01/14/2025 | 10/24/2025 | UH2 |
| Cancer Immunoprevention Network (CIP-Net) Resource Coordinating Center (U24 Clinical Trials Not Allowed) | RFA-CA-24-036 | 11/02/2024 | 12/03/2024 | U24 |
| Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed) | PAR-24-277 | 09/05/2024 | 11/06/2024 | R01 |
| Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) | PAR-24-291 | 09/16/2024 | 11/17/2024 | R21 |
| Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed) | PAR-25-044 | 01/16/2025 | 01/08/2028 | R21 |
| Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional) | PAR-25-043 | 01/05/2025 | 01/08/2028 | R01 |
| Notice of Special Interest: Women’s Health Research | NOT-OD-24-079 | 03/26/2024 | 11/05/2027 | N/A |
| RNA Modifications Driving Oncogenesis (RNAMoDO; U01 Clinical Trial Not Allowed) | RFA-CA-24-029 | 10/04/2024 | 11/05/2024 | U01 |
| NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed) | RFA-OD-24-011 | 11/04/2024 | 12/05/2026 | R50 |
| Building Sustainable Software Tools for Open Science (R03 Clinical Trial Not Allowed) | RFA-OD-24-010 | 11/04/2024 | 12/05/2026 | R03 |
| Notice of Special Interest (NOSI): Understanding the Basic Mechanisms of Immune-related Adverse Events (irAEs) in Cancer Immunotherapy | NOT-CA-24-055 | 07/11/2024 | 11/06/2027 | N/A |
| Notice of Special Interest (NOSI): Conferences and Scientific Meetings in Cancer Biology | NOT-CA-24-059 | 06/04/2024 | 12/13/2024 | R13 |
| Support for Research Excellence – First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed) | PAR-24-145 | 04/29/2024 | 01/08/2027 | R16 |
| Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed) | PAR-24-144 | 04/29/2024 | 01/08/2027 | R16 |
| Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed) | PAR-21-294 | 09/05/2021 | 01/08/2025 | R01 |
| Notice of Special Interest (NOSI): Exploratory Cancer Immunology Projects and Technologies (ExCITe) | NOT-CA-24-016 | 12/05/2023 | 11/17/2026 | R21 |
| Notice of Special Interest (NOSI): Research Projects to Develop Oncoaging Models for Cancer Research | NOT-CA-23-092 | 10/16/2023 | 07/31/2027 | N/A |
| Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed) | PAR-23-281 | 09/05/2023 | 09/08/2026 | R01 |
| Notice of Special Interest (NOSI): Research on HIV-associated Malignancies | NOT-CA-23-070 | 06/08/2023 | 09/08/2026 | N/A |
| Translational Research Toward Development of a Kaposi Sarcoma Herpesvirus (KSHV) Vaccine (U01 Clinical Trial Optional) | RFA-CA-24-006 | 11/21/2023 | 12/05/2024 | U01 |
| Notice of Special Interest (NOSI): RNA Modifications in Cancer Biology | NOT-CA-23-060 | 04/17/2023 | 01/08/2026 | N/A |
| Notice of Special Interest (NOSI): Synthetic Biology for Biomedical Applications | NOT-EB-23-002 | 04/14/2023 | 05/17/2026 | N/A |
| Adaptive Biomaterials for Cancer Biology | NOT-CA-23-030 | 01/10/2023 | 05/07/2025 | N/A |
| Biology of Bladder Cancer (R01 Clinical Trial Optional) | PAR-22-218 | 09/05/2022 | 09/08/2025 | R01 |
| Biology of Bladder Cancer (R21 Clinical Trial Optional) | PAR-22-219 | 09/16/2022 | 09/08/2025 | R21 |
| The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed) | PAR-25-130 | 05/20/2025 | 06/21/2025 | U01 |
| Notice of Special Interest (NOSI): Basic Mechanisms of Cannabis and Cannabinoid Action in Cancer | NOT-CA-22-085 | 05/05/2022 | 05/08/2027 | N/A |
| Research Projects in Physical Sciences-Oncology (U01 Clinical Trial Optional) | PAR-22-147 | 06/08/2022 | 11/02/2024 | U01 |
| Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional) | PAR-22-114 | 08/06/2022 | 01/24/2025 | N/A |
| Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R01 Clinical Trial Not Allowed) | PAR-22-085 | 05/05/2022 | 05/08/2025 | R01 |
| Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R21 Clinical Trial Not Allowed) | PAR-22-086 | 05/16/2022 | 05/08/2025 | R21 |
| Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) | PAR-22-099 | 05/05/2022 | 05/08/2025 | R01 |
| Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R01 Clinical Trial Not Allowed) | PAR-22-061 | 01/05/2022 | 01/08/2025 | R01 |
| Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R21 Clinical Trial Not Allowed) | PAR-22-062 | 01/16/2022 | 01/08/2025 | R21 |
| Notice of Special Interest (NOSI): Developing Academic Research Enhancement Award (AREA) and Research Enhancement Award Program (REAP) for Institutions with an emphasis on Down syndrome research (R15 Clinical Trial Not Allowed) | NOT-OD-22-136 | 05/31/2022 | 04/11/2025 | N/A |
| Development of Animal Models and Related Biological Materials for Down Syndrome Research (R24 Clinical Trials Not-Allowed) | PAR-22-247 | 11/01/2022 | 05/26/2025 | R24 |
| Notice of Special Interest (NOSI): NIH Research Project Grants on Down Syndrome (R01) for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project | NOT-OD-22-123 | 05/26/2022 | 05/01/2025 | R01 |
| Notice of Special Interest (NOSI): Availability of Administrative Supplements for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project | NOT-OD-22-137 | 06/07/2022 | 06/02/2025 | N/A |
| Development of Animal Models and Related Biological Materials for Down Syndrome Research (R21 Clinical Trials Not Allowed) | PAR-23-067 | 02/20/2023 | 01/08/2026 | R21 |
| Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 Clinical Trial Optional) | PAR-21-138 | 06/07/2021 | 12/02/2024 | N/A |
| Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) | PA-23-189 | 06/29/2023 | 05/08/2026 | N/A |
|
Mechanistic links between diet, lipid metabolism, and tumor growth and progression (U01 Clinical Trial Not Allowed) |
PAR-23-051 | 01/17/2023 | 04/24/2025 | U01 |
|
Mechanistic links between diet, lipid metabolism, and tumor growth and progression (UH2 Clinical Trial Not Allowed) |
01/17/2023 | 10/24/2025 | UH2 |